More on DNTH

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+3.1% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Dianthus Therapeutics (NQ:DNTH)
Delayed: 76.78 -1.75 (2.23%)
Prev. Close $78.53  
Open$76.03 
52 Wk High$ 
52 Wk Low$ 
Day High$78.16 
Day Low$76.02 
P/E N/A  
EPS$ 
Volume379,234 

Friends, Peers and Foes (?): CRSP, SNY, AGMB, BIIB, ALNY (more...)

Oct 13, 2026 08:45 AM Dianthus Therapeutics Recognized Among Fortune’s 2026 Best Workplaces In BioPharma
Oct 1, 2026 05:00 PM Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 1, 2026 07:11 AM William Blair Adjusts October Analyst Conviction List Names
Sep 29, 2026 08:00 AM Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting
Sep 18, 2026 04:36 PM Form 4 Dianthus Therapeutics, For: Sep 17 Filed by: CARR EDWARD
Sep 18, 2026 04:08 PM Dianthus Therapeutics (DNTH) files mixed shelf
Sep 18, 2026 04:02 PM Form S-3ASR Dianthus Therapeutics,
Sep 17, 2026 04:28 PM Form 144 Dianthus Therapeutics, Filed by: CARR EDWARD
Sep 11, 2026 03:26 AM JPMorgan Starts Dianthus Therapeutics (DNTH) at Overweight
Sep 4, 2026 05:09 AM Citi initiates Dianthus Therapeutics coverage with Buy rating
View All Articles

Entities mentioned with DNTH

View All Entities